Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.

Sulahian A, Porcher R, Bergeron A, Touratier S, Raffoux E, Menotti J, Derouin F, Ribaud P.

J Clin Microbiol. 2014 Jul;52(7):2328-33. doi: 10.1128/JCM.03567-13. Epub 2014 Apr 16.

2.

Bayesian development of a dose-response model for Aspergillus fumigatus and invasive aspergillosis.

Leleu C, Menotti J, Meneceur P, Choukri F, Sulahian A, Garin YJ, Denis JB, Derouin F.

Risk Anal. 2013 Aug;33(8):1441-53. doi: 10.1111/risa.12007. Epub 2013 Jan 11.

PMID:
23311627
3.

Efficacy of liposomal amphotericin B for prophylaxis of acute or reactivation models of invasive pulmonary aspergillosis.

Leleu C, Menotti J, Meneceur P, Choukri F, Sulahian A, Garin YJ, Derouin F.

Mycoses. 2013 May;56(3):241-9. doi: 10.1111/myc.12011. Epub 2012 Sep 24.

PMID:
22998025
4.

Response assessment in invasive aspergillosis.

Bergeron A, Porcher R, Raffoux E, Sulahian A, Ribaud P.

Clin Infect Dis. 2012 Aug;55(3):475-6; author reply 476-7. doi: 10.1093/cid/cis415. Epub 2012 May 4. No abstract available.

PMID:
22563023
5.

Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.

Salmeron G, Porcher R, Bergeron A, Robin M, Peffault de Latour R, Ferry C, Rocha V, Petropoulou A, Xhaard A, Lacroix C, Sulahian A, Socié G, Ribaud P.

Haematologica. 2012 Sep;97(9):1357-63. doi: 10.3324/haematol.2011.058255. Epub 2012 Feb 27.

6.

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.

Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, Cornet M, Isnard F, Raffoux E, Brethon B, Lacroix C, Touratier S, Latgé JP, Bouges-Michel C, Tazi A, Derouin F, Ribaud P, Sulahian A.

J Clin Microbiol. 2012 Mar;50(3):823-30. doi: 10.1128/JCM.00750-11. Epub 2011 Dec 14.

7.

The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies.

Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, Lacroix C, Poirot JL, Bouges C, Derouin F, Tazi A, Ribaud P.

Blood. 2012 Feb 23;119(8):1831-7; quiz 1956. doi: 10.1182/blood-2011-04-351601. Epub 2011 Oct 18.

PMID:
22010103
8.

Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid samples of patients living in France.

Yera H, Dupont D, Houze S, Ben M'rad M, Pilleux F, Sulahian A, Gatey C, Gay Andrieu F, Dupouy-Camet J.

J Clin Microbiol. 2011 Dec;49(12):4338-40. doi: 10.1128/JCM.05839-11. Epub 2011 Oct 5.

9.

Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.

Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, Raffoux E, Arnulf B, Socié G, Ribaud P, Tazi A.

Chest. 2010 Feb;137(2):410-5. doi: 10.1378/chest.09-0701. Epub 2009 Oct 3.

PMID:
19801584
10.

Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases.

Gallien S, Fournier S, Porcher R, Bottero J, Ribaud P, Sulahian A, Socié G, Molina JM.

Infection. 2008 Dec;36(6):533-8. doi: 10.1007/s15010-008-7375-x. Epub 2008 Nov 13. Review.

PMID:
19011743
11.

Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A.

J Clin Microbiol. 2008 Mar;46(3):1009-13. Epub 2007 Dec 26.

12.

Recombinant antigens as diagnostic markers for aspergillosis.

Sarfati J, Monod M, Recco P, Sulahian A, Pinel C, Candolfi E, Fontaine T, Debeaupuis JP, Tabouret M, Latgé JP.

Diagn Microbiol Infect Dis. 2006 Aug;55(4):279-91. Epub 2006 Apr 19.

PMID:
16626916
13.

Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.

Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, Rousselot P, Raffoux E, Menotti J, Derouin F, Ribaud P, Sulahian A.

J Clin Microbiol. 2006 Feb;44(2):389-94.

14.

Late-onset eosinophilic chronic meningitis occurring 30 years after Taenia solium infestation in a white Caucasian woman.

Castillo-Iglesias H, Mouly S, Ducros A, Sarfati C, Sulahian A, Bergmann JF.

J Infect. 2006 Jul;53(1):e35-8. Epub 2005 Oct 25.

PMID:
16253336
15.

Development and evaluation of a Western blot kit for diagnosis of schistosomiasis.

Sulahian A, Garin YJ, Izri A, Verret C, Delaunay P, van Gool T, Derouin F.

Clin Diagn Lab Immunol. 2005 Apr;12(4):548-51.

16.

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

Sulahian A, Touratier S, Ribaud P.

N Engl J Med. 2003 Dec 11;349(24):2366-7. No abstract available.

PMID:
14668472
17.

Microplate method for obtaining Leishmania clonal populations.

Garin YJ, Meneceur P, Sulahian A, Derouin F.

J Parasitol. 2002 Aug;88(4):803-4.

PMID:
12197138
18.

Experimental pathogenicity of a presumed monoxenous trypanosomatid isolated from humans in a murine model.

Garin YJ, Sulahian A, Méneceur P, Pratlong F, Prina E, Gangneux J, Dedet JP, Derouin F.

J Eukaryot Microbiol. 2001 Mar-Apr;48(2):170-6.

PMID:
12095104
19.

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease.

Boutboul F, Alberti C, Leblanc T, Sulahian A, Gluckman E, Derouin F, Ribaud P.

Clin Infect Dis. 2002 Apr 1;34(7):939-43. Epub 2002 Feb 20.

PMID:
11880959
20.

Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections.

Garin YJ, Sulahian A, Pratlong F, Meneceur P, Gangneux JP, Prina E, Dedet JP, Derouin F.

Infect Immun. 2001 Dec;69(12):7365-73.

21.

Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice.

Bretagne S, Durand R, Olivi M, Garin JF, Sulahian A, Rivollet D, Vidaud M, Deniau M.

Clin Diagn Lab Immunol. 2001 Jul;8(4):828-31.

22.

Assessment of Leishmania promastigote growth in vitro by means of nucleoside hydrolase activity determination.

Garin YJ, Sulahian A, Meneceur P, Gangneux JP, Pannier-Stockman C, Derouin F.

Parasitol Res. 2001 Feb;87(2):145-8.

PMID:
11206112
24.
25.

Effects of immunosuppressive therapy on murine Leishmania infantum visceral leishmaniosis.

Gangneux JP, Chau F, Sulahian A, Derouin F, Garin YJ.

Eur Cytokine Netw. 1999 Dec;10(4):557-9.

26.

Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.

Gangneux JP, Dullin M, Sulahian A, Garin YJ, Derouin F.

Antimicrob Agents Chemother. 1999 Jan;43(1):172-4.

27.

Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection.

Honoré S, Garin YJ, Sulahian A, Gangneux JP, Derouin F.

FEMS Immunol Med Microbiol. 1998 Jul;21(3):231-9.

29.
30.

Activity of IFN-gamma in experimental Leishmania infantum murine visceral leishmaniasis.

Garin YJ, Sulahian A, Gangneux JP, Derouin F.

Pathol Biol (Paris). 1997 Jan;45(1):48-51.

PMID:
9097846
31.

Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum.

Gangneux JP, Sulahian A, Garin YJ, Derouin F.

Trans R Soc Trop Med Hyg. 1996 Sep-Oct;90(5):574-7.

PMID:
8944278
32.

Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum.

Buffet PA, Garin YJ, Sulahian A, Nassar N, Derouin F.

Ann Trop Med Parasitol. 1996 Jun;90(3):295-302.

PMID:
8758143
33.

Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

Gangneux JP, Sulahian A, Garin YJ, Farinotti R, Derouin F.

Antimicrob Agents Chemother. 1996 May;40(5):1214-8.

34.

Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis.

Sulahian A, Tabouret M, Ribaud P, Sarfati J, Gluckman E, Latgé JP, Derouin F.

Eur J Clin Microbiol Infect Dis. 1996 Feb;15(2):139-45.

PMID:
8801086
35.

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice.

Buffet PA, Sulahian A, Garin YJ, Nassar N, Derouin F.

Antimicrob Agents Chemother. 1995 Sep;39(9):2167-8.

36.

[Appendiceal localization of bilharziasis: value of extemporaneous histological examination].

Panis Y, Kaisserian G, Sulahian A, Hoang C, Gallian A, Valleur P.

Ann Chir. 1994;48(4):374-6. French.

PMID:
8085764
37.

Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study.

Saugier-Veber P, Devergie A, Sulahian A, Ribaud P, Traore F, Bourdeau-Esperou H, Gluckman E, Derouin F.

Bone Marrow Transplant. 1993 Aug;12(2):121-4.

PMID:
8401356
38.

[Techniques applicable to broncho-alveolar lavage fluid in hospital laboratory for the diagnosis of parasitic and fungal pneumopathies in immunosuppressed patients].

Beauvais B, Traore F, Sarfati C, Derouin F, Sulahian A, Gerber F, Lariviere M.

Ann Biol Clin (Paris). 1991;49(3):172-9. Review. French.

PMID:
2064088
39.

Longitudinal study of the specific humoral and cellular response to Toxoplasma gondii in a patient with acquired toxoplasmosis.

Derouin F, Rabian-Herzog C, Sulahian A.

J Clin Lab Immunol. 1989 Oct;30(2):97-102.

PMID:
2641536
40.

Dirofilariasis of the breast in france.

Pinon JM, Dousset H, Ologoudou L, Sulahian A, Adnet JJ.

Am J Trop Med Hyg. 1980 Sep;29(5):1018-9.

PMID:
7435780
42.

[A critical study of immuno-enzymatic reactions coupled with the precipitation tests on cellulose acetate membranes].

Pinon JM, Charpentier O, Level MC, Remy G, Sulahian A, Dropsy G.

Bull Soc Pathol Exot Filiales. 1978 Mar-Apr;71(2):189-95. French.

PMID:
369730
43.
44.

[Filarial eosinophilic lung diseases, value of immunology (apropos of 9 cases)].

Gentilini M, Pinon JM, Sulahian A, Nosny Y, Maillard F.

Bull Soc Pathol Exot Filiales. 1975 Sep-Oct;68(5):496-503. French.

PMID:
779992
45.

An 18-month longitudinal lymphographic study of filarial diseases in dogs infected with Brugia pahangi (Buckley and Edeson, 1956).

Schacher JF, Edeson JF, Sulahian A, Rizk G.

Ann Trop Med Parasitol. 1973 Mar;67(1):81-94. No abstract available.

PMID:
4353079
46.

Lymphatic drainage patterns and experimental filariasis in dogs.

Schacher JF, Sulahian A.

Ann Trop Med Parasitol. 1972 Jun;66(2):209-17. No abstract available.

PMID:
5038246
47.

Direct lymphangiography in dogs infected with Brugia pahangi (Buckley and Edeson 1956).

Schacher JF, Edeson JF, Sulahian A, Rizk G.

Trans R Soc Trop Med Hyg. 1970;64(1):23-4. No abstract available.

PMID:
5442078
48.

Experimental lymphoedema in dogs infected with Brugia spp.

Schacher JF, Sulahian A, Edeson JF.

Trans R Soc Trop Med Hyg. 1969;63(5):682-4. No abstract available.

PMID:
5824292

Supplemental Content

Loading ...
Support Center